Rotavirus Vaccine

Manufacturing

GSK's rotavirus shot runs short due to manufacturing issues

GSK faces an "unplanned, short-term drop in Rotarix production for 2022," thanks to unspecified "manufacturing challenges," the company told Fierce.
Fraiser Kansteiner Aug 11, 2022 4:00pm

FiercePharmaAsia—Amgen, Gilead, and more

Sep 29, 2017 8:19am

FiercePharmaAsia—WuXi AppTec, Shionogi and Purdue, EMA

Mar 31, 2017 8:46am

Serum’s heat-stable rotavirus vaccine shines in phase 3

Mar 28, 2017 2:07pm